Ionis Pharmaceuticals, Inc. Common Stock (IONS) News

Seeking Alpha 15d ago

Roche, Ionis succeed in late-stage trial for kidney disease therapy

General T2IONS

Investing.com 15d ago

Canaccord reiterates Ionis stock rating on positive trial results

General T3IONS

Investing.com 15d ago

Ionis, Roche report positive phase 3 data for kidney drug

General T3IONS

Seeking Alpha 16d ago

Ionis gains on late-stage trial results for ulefnersen in ALS

General T2IONS

Reuters 16d ago

Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study

General T1IONS

Investing.com 16d ago

Ionis drug meets primary goal in rare ALS gene mutation trial

General T3IONS

Motley Fool 18d ago

Investors Dumped Ionis Pharmaceuticals Stock -- But Wall Street Hasn't Budged From Its Bullish Outlook

Shares of Ionis are down more than 40% so far this year.

General T3IONS

Investing.com 20d ago

Ionis stock falls 44% as InvestingPro Fair Value predicted overvaluation

General T3IONS

Yahoo Finance 21d ago

Novartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage Trial

General T2IONSNVS

Seeking Alpha News 22d ago

Ionis Pharmaceuticals, Inc. (IONS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2IONS

Yahoo Finance 28d ago

BofA Sees Limited Damage from Novartis (NVS)’ Pelacarsen Miss While Citi Looks Towards Ionis (IONS)

General T2CIONSNVS

Seeking Alpha News 28d ago

Ionis Pharmaceuticals, Inc. (IONS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

General T2IONS

Motley Fool 29d ago

Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.

Ionis Pharmaceuticals is promising in multiple ways -- but it's not dirt cheap or without risks.

General T3IONS